A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2009
At a glance
- Drugs AZD 7268 (Primary)
- Indications Anxiety disorders; Depressive disorders
- Focus Adverse reactions
- 13 May 2009 Actual initiation date (December 2008), actual patient number (48) and actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 13 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Nov 2008 New trial record.